MiR-218 was also found to inhibit epithelial-mesenchymal transition (EMT), migration, and invasion by targeting SFMBT1 and DCUN1D1, and was downregulated in cervical cancer [46]. Here, SFMBT1 is linked to cervical carcinoma.